AstraZeneca Unloads Four NDAs to ANI Pharmaceuticals in $46.5M Deal Post author:Sam Post published:December 28, 2017 Post category:BioPharma ANI Phamaceuticals funded the acquisitions through a combination of cash and debt. Source: BioSpace You Might Also Like <b>Repare Therapeutics</b> Bursts From Stealth Mode With $68 Million and a Team Packed With Industry Alums June 21, 2017 Onxeo To Present Data Supporting Three Key Orphan Oncology Assets At AACR Annual Meeting March 20, 2017 Aldeyra Reports Full Year 2016 Financial Results March 30, 2017
<b>Repare Therapeutics</b> Bursts From Stealth Mode With $68 Million and a Team Packed With Industry Alums June 21, 2017
Onxeo To Present Data Supporting Three Key Orphan Oncology Assets At AACR Annual Meeting March 20, 2017
